These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27387685)

  • 21. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer.
    Thronicke A; Steele ML; Grah C; Matthes B; Schad F
    BMC Complement Altern Med; 2017 Dec; 17(1):534. PubMed ID: 29237435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.
    Mabed M; El-Helw L; Shamaa S
    Br J Cancer; 2004 Jan; 90(1):65-9. PubMed ID: 14710208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient' and social aspects related to complementary mistletoe therapy in patients with breast cancer: A systematic review commissioned by the German agency for Health Technology Assessment.
    Steigenberger C; Schnell-Inderst P; Flatscher-Thöni M; Plank LM; Siebert U
    Eur J Oncol Nurs; 2023 Aug; 65():102338. PubMed ID: 37321128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mistletoe therapy in cancer treatment: pros and cons].
    Wiebelitz KR; Beer AM; Heinrich B
    MMW Fortschr Med; 2009 Nov; 151(46):30-1. PubMed ID: 20043390
    [No Abstract]   [Full Text] [Related]  

  • 25. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
    Kast A; Hauser SP
    Schweiz Rundsch Med Prax; 1990 Mar; 79(11):332-4. PubMed ID: 2315589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete remission and long-term survival of a patient with melanoma metastases treated with high-dose fever-inducing Viscum album extract: A case report.
    Werthmann PG; Hintze A; Kienle GS
    Medicine (Baltimore); 2017 Nov; 96(46):e8731. PubMed ID: 29145317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Possibilities and limits of mistletoe therapy in cancer patients].
    Hoffmann J
    Arch Gynecol Obstet; 1987; 242(1-4):257-60. PubMed ID: 3688952
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial.
    Piao BK; Wang YX; Xie GR; Mansmann U; Matthes H; Beuth J; Lin HS
    Anticancer Res; 2004; 24(1):303-9. PubMed ID: 15015612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mistletoe therapy. An alternative cancer treatment].
    Ernst E
    MMW Fortschr Med; 2000 Nov; 142(45):52-3. PubMed ID: 11107826
    [No Abstract]   [Full Text] [Related]  

  • 31. Case reports of sarcoma patients with optimized lectin-oriented mistletoe extract therapy.
    Kirsch A; Hajto T
    J Altern Complement Med; 2011 Oct; 17(10):973-9. PubMed ID: 22010781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
    Bar-Sela G; Gershony A; Haim N
    Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial.
    Friess H; Beger HG; Kunz J; Funk N; Schilling M; Büchler MW
    Anticancer Res; 1996; 16(2):915-20. PubMed ID: 8687151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of mistletoe therapy in carcinoma patients].
    Rostock M; Unger C
    Internist (Berl); 1998 Dec; 39(12):1294-5. PubMed ID: 10198836
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiproliferative and anticarcinogenic effects of an aqueous preparation of Abies alba and Viscum album se abies, on a L-1210 malignant cell line and tumor-bearing Wistar rats.
    Karkabounas S; Assimakopoulos D; Malamas M; Skaltsounis AL; Leonce S; Zelovitis J; Stefanou D; Evangelou A
    Anticancer Res; 2000; 20(6B):4391-5. PubMed ID: 11205277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metaphorical aspects of mistletoe therapy in patients' experiences--a qualitative study].
    Konitzer M; Doering T; Fischer GC
    Forsch Komplementarmed Klass Naturheilkd; 2001 Apr; 8(2):68-79. PubMed ID: 11340313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients.
    Bock PR; Hanisch J; Matthes H; Zänker KS
    Inflamm Allergy Drug Targets; 2014; 13(2):105-11. PubMed ID: 24766319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anthroposophy. Mistletoe preparations: a cancer inhibiting wonder drug?].
    Arm F
    Krankenpfl Soins Infirm; 1989 May; 82(5):18-21. PubMed ID: 2747189
    [No Abstract]   [Full Text] [Related]  

  • 39. The case for mistletoe in the treatment of laryngeal cancer.
    Shakeel M; Trinidade A; Geider S; Ah-See KW
    J Laryngol Otol; 2014 Mar; 128(3):302-6. PubMed ID: 24548675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Helixor--mistletoe preparation for cancer therapy. Documentation No. 19].
    Kast A; Hauser SP
    Schweiz Rundsch Med Prax; 1990 Mar; 79(10):291-5. PubMed ID: 2180032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.